These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 8927326)

  • 21. 13C-mixed triglyceride breath test to assess oral enzyme substitution therapy in patients with chronic pancreatitis.
    Domínguez-Muñoz JE; Iglesias-García J; Vilariño-Insua M; Iglesias-Rey M
    Clin Gastroenterol Hepatol; 2007 Apr; 5(4):484-8. PubMed ID: 17445754
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Pancreatic enzymes with pH-dependent liberation].
    Baumer P
    Ann Gastroenterol Hepatol (Paris); 1987 Dec; 23(7):375-87. PubMed ID: 3324928
    [No Abstract]   [Full Text] [Related]  

  • 23. Blood levels of certain vitamins in patients with chronic pancreatitis. Effect of substitutive treatment with pancreatic extracts.
    Dzieniszewski J; Wartanowicz M; Jarosz O; Ziemlański S
    Mater Med Pol; 1984; 16(2-4):71-4. PubMed ID: 6535050
    [No Abstract]   [Full Text] [Related]  

  • 24. Comparative study of serum trypsin levels and pancreatic exocrine function in chronic pancreatitis.
    Gullo L; Ventrucci M; Bonora G; Gori G; Vezzadini P
    Scand J Gastroenterol Suppl; 1980; 62():27-8. PubMed ID: 6935751
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pancreatic steatorrhea: action of a total lyophilized pancreas preparation: an "in vitro" and "in vivo" study.
    Dani R; Ribeiro TC; Penna FJ; Nogueira CE
    Arq Gastroenterol; 1986; 23(3):152-8. PubMed ID: 3435264
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The impact of pancreatic enzyme supplementation on postprandial responses of glucagon-like Peptide-2 in patients with chronic pancreatitis and pancreatic exocrine insufficiency.
    Knop FK; Vilsbøll T; Lund A; Krarup T; Holst JJ; Hornum M
    JOP; 2010 Sep; 11(5):489-91. PubMed ID: 20818126
    [No Abstract]   [Full Text] [Related]  

  • 27. [Substitution therapy in insufficient external pancreatic secretion].
    Simek I; Duda M; Kubias K
    Vnitr Lek; 1993 Mar; 39(3):250-2. PubMed ID: 8506676
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Therapy with pancreatic enzyme preparations].
    Holtmann G; Layer P
    Med Monatsschr Pharm; 1993 Feb; 16(2):38-42. PubMed ID: 8441359
    [No Abstract]   [Full Text] [Related]  

  • 29. [Evaluation by the PABA test of the effects of cimetidine combined with pancreatic extracts in severe pancreatic insufficiency].
    Delchier JC; Soulé JC; Pariente EA; Bader JP
    Gastroenterol Clin Biol; 1983; 7(6-7):636-8. PubMed ID: 6603384
    [No Abstract]   [Full Text] [Related]  

  • 30. [Comparative clinical study of Neopanpur and Creon].
    Beró T; Jávor T
    Orv Hetil; 1994 Jan; 135(1):7-14. PubMed ID: 8290236
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Use of Panzytrat in the replacement therapy of exocrine pancreatic insufficiency (an analytical review)].
    Karamysheva EI; Lobanova EG
    Eksp Klin Gastroenterol; 2002; (4):47-50, 132. PubMed ID: 12503276
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Can the natural history of exocrine pancreatic insufficiency be influenced at some stage in chronic pancreatitis?].
    Bernard JP
    Gastroenterol Clin Biol; 2003 Mar; 27(3 Suppl):S51-5. PubMed ID: 12704294
    [No Abstract]   [Full Text] [Related]  

  • 33. Adequate enzymatic substitution in treating exocrine pancreatic insufficiency.
    Simek I; Kubias K; Duda M
    Acta Physiol Hung; 1992; 80(1-4):417-21. PubMed ID: 1364280
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enteropeptidase (EC 3.4.21.9) in coeliac disease and exocrine pancreatic insufficiency.
    Gregar I; Kojecký Z; Lojda Z; Matlocha Z
    Acta Univ Palacki Olomuc Fac Med; 1987; 116():247-52. PubMed ID: 2962436
    [No Abstract]   [Full Text] [Related]  

  • 35. Proteolytic inactivation of lipase as a possible cause of the uneven results obtained with enzyme substitution in pancreatic insufficiency.
    Pap A; Varró V
    Hepatogastroenterology; 1984 Feb; 31(1):47-50. PubMed ID: 6199274
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Differential therapy of exocrine pancreatic insufficiency--current aspects and future prospects of substitution therapy with pancreatic enzymes].
    Löser C; Fölsch UR
    Z Gastroenterol; 1995 Dec; 33(12):715-22. PubMed ID: 8585255
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pancreatic enzyme pharmacotherapy.
    Ferrone M; Raimondo M; Scolapio JS
    Pharmacotherapy; 2007 Jun; 27(6):910-20. PubMed ID: 17542772
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Treatment of exocrine pancreatic insufficiency: what gastroprotection do pancreatic enzymes provide?].
    Zylberberg P; Delchier JC
    Gastroenterol Clin Biol; 1993; 17(11):816-22. PubMed ID: 8143947
    [No Abstract]   [Full Text] [Related]  

  • 39. Response to long-term enzyme replacement treatment in dogs with exocrine pancreatic insufficiency.
    Wiberg ME; Lautala HM; Westermarck E
    J Am Vet Med Assoc; 1998 Jul; 213(1):86-90. PubMed ID: 9656030
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Exocrine pancreatic insufficiency. Comparison of substitution therapy with a non-acid resistant and an acid resistant enzyme preparation].
    Freise J; Horstkotte H
    Fortschr Med; 1986 Sep; 104(33):625-8. PubMed ID: 3639835
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.